What the Saiontz & Kirk, P.A. TV commercial - Zostavax Shingles Vaccine is about.
Saiontz & Kirk, P.A. is a law firm that focuses on personal injury cases, including those that result from dangerous drugs and faulty medical devices. In one of their TV spots, they discuss the risks associated with the Zostavax shingles vaccine.
The spot begins with a warning that the vaccine has been linked to serious side effects, including blindness, paralysis, and even death. It notes that many people have suffered these side effects after receiving the vaccine, and that lawsuits have been filed over the issue.
The focus of the spot is on helping those who have been harmed by the vaccine. It invites viewers who have experienced side effects to contact Saiontz & Kirk, P.A. for a free consultation about their legal options.
Throughout the spot, Saiontz & Kirk, P.A. emphasizes their experience in handling cases related to dangerous drugs and medical devices. They also highlight their commitment to fighting for their clients and seeking justice.
Overall, the TV spot from Saiontz & Kirk, P.A. is a sobering reminder of the risks associated with the Zostavax shingles vaccine, and a call to action for those who have suffered side effects to seek legal help.
Saiontz & Kirk, P.A. TV commercial - Zostavax Shingles Vaccine produced for
Saiontz & Kirk, P.A.
was first shown on television on April 2, 2019.
Frequently Asked Questions about saiontz & kirk, p.a. tv spot, 'zostavax shingles vaccine'
Zostavax®, the shingles vaccine, reduced the risk of shingles by 51% and the risk of post-herpetic neuralgia by 67% based on a large study of more than 38,000 adults aged 60 years or older. Protection from shingles vaccine lasts about 5 years.
Merck
Zostavax (Merck), in use since 2006, is an attenuated vaccine which consists of a larger-than-normal dose of chickenpox vaccine. Unlike Shingrix, Zostavax is not suitable for people with immunosuppression or diseases that affect the immune system.
Zostavax shingles vaccine discontinued by supplier
In August 2020, Merck Sharpe and Dohme (MSD) advised Pharmac that it would be discontinuing supply of its zoster vaccine (Zostavax) as it intended to convert its zoster manufacturing sites over to manufacture of its developmental COVID-19 vaccine.
August 18, 2021 Update: The shingles vaccine lawsuit in the MDL was originally filed on behalf of 22 plaintiffs. In August 2021, it is now over 2130. The first Zostavax trial will be on January 18, 2022. The outcome of this trial will have an impact on the ultimate settlement compensation payouts in these lawsuits.
For Zostavax, a single dose is recommended. For Shingrix, 2 doses are recommended. There is currently no booster recommendation for either zoster vaccine.
Zostavax (zoster vaccine live) was licensed by the FDA in 2006. This vaccine reduces the risk of developing shingles by 51% and PHN by 67%. It is given in one dose as a shot, and can be given in a doctor's office or pharmacy.
Currently, shingles vaccination with the Zostavax® vaccine is free under the NIP for immunocompetent adults aged 70 years.
Two doses of Shingrix provide strong protection against shingles and postherpetic neuralgia (PHN), the most common complication of shingles. In adults 50 to 69 years old with healthy immune systems, Shingrix was 97% effective in preventing shingles; in adults 70 years and older, Shingrix was 91% effective.
ZOSTAVAX is a vaccine that is used for adults 50 years of age or older to prevent shingles (also known as zoster). ZOSTAVAX contains a weakened chickenpox virus (varicella-zoster virus). ZOSTAVAX works by helping your immune system protect you from getting shingles.
CDC recommends a single dose of Zostavax® (zoster vaccine live) for people 60 years old or older, whether or not the person reported a prior episode of herpes zoster (shingles).
Signs of an allergic reaction happen within minutes or hours after vaccination and include hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness. If you experience these or any other life-threatening symptoms, see a doctor right away.
Most people got a sore arm with mild or moderate pain after getting Shingrix, and some also had redness and swelling where they got the shot. Some people felt tired, had muscle pain, a headache, shivering, fever, stomach pain, or nausea.
